Rituximab induces clinical stabilization in a patient with fulminant multiple sclerosis not responding to natalizumab. Evidence for disease heterogeneity - Leussink, V I; Lehmann, H C; Meyer zu Hörste, G; Hartung, H P; Stüve, O; Kieseier, B C (J Neurol, 2008)